Vivo Capital’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $35K | Hold |
|
|||||
|
2021
Q4 | $22K | Sell |
|
|||||
|
2021
Q3 | $3.14M | Sell |
|
|||||
|
2021
Q2 | $15.3M | Hold |
|
|||||
|
2021
Q1 | $15.9M | Hold |
|
|||||
|
2020
Q4 | $22M | Hold |
|
|||||
|
2020
Q3 | $14.6M | Hold |
|
|||||
|
2020
Q2 | $17.2M | Hold |
|
|||||
|
2020
Q1 | $12.2M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $19M | Hold |
|
|||||
|
2019
Q1 | $25M | Hold |
|
|||||
|
2018
Q4 | $18.2M | Hold |
|
|||||
|
2018
Q3 | $21.5M | Hold |
|
|||||
|
2018
Q2 | $21.9M | Hold |
|
|||||
|
2018
Q1 | $17.6M | Hold |
|
|||||
|
2017
Q4 | $25M | Buy |
|
|||||
|
2017
Q3 | $19.7M | Hold |
|
|||||
|
2017
Q2 | $14.1M | Hold |
|
|||||
|
2017
Q1 | $20.5M | Hold |
|
|||||
|
2016
Q4 | $20.8M | Hold |
|
|||||
|
2016
Q3 | $23.9M | Buy |
|
|||||
|
2016
Q2 | $31.7M | Hold |
|
|||||
|
2016
Q1 | $26.8M | Buy |
|